About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Alogliptin and Pioglitazone - Indications, Dosage, Side Effects and Precautions

Font : A-A+

Information about Alogliptin and Pioglitazone

Generic Name : Alogliptin and Pioglitazone
Latest prescription information about Alogliptin and Pioglitazone. Learn its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, warnings and its storage instructions . Also listed are the International and Indian trade name(s) of the drug and its price list.
Advertisement

Trade Names/Brand Names of Alogliptin and Pioglitazone

International- Oseni.
Advertisement

Why is Alogliptin and Pioglitazone Prescribed? (Indications)

Alogliptin and Pioglitazone combination is used to treat high blood sugar level in patients with type 2 diabetes along with diet control and exercise. This combination should not be used to treat type 1 diabetes.

This combination medication contains pioglitazone, a thiazolidinedione agent and alogliptin, a DPP-4 inhibitor.  
Advertisement

When should Alogliptin and Pioglitazone not be taken? (Contraindications)

Contraindicated in patients who have severe heart failure, and known hypersensitivity.

What is the dosage of Alogliptin and Pioglitazone?

Dose is based on patient’s condition. Maximum recommended dose is 25/45mg.

How should Alogliptin and Pioglitazone be taken?

It comes as a tablet, which contains 25 mg alogliptin and 15 mg pioglitazone to take by mouth, with or without food.

What are the warnings and precautions for Alogliptin and Pioglitazone?

• Caution should be exercised in patients with history of heart failure, diabetic eye disease, eye swelling, kidney or liver impairment, bladder cancer, acute pancreatitis, fluid retention, fractures, hypoglycemia (abnormal decrease in blood sugar), premenopausal woman, any allergy, who are taking other medications, during pregnancy and breastfeeding.

• Follow diet and exercise program as directed by your physician.

• Monitor blood sugar level regularly while taking this medication.

• Perform eye examination regularly while taking this medication.

What are the side effects of Alogliptin and Pioglitazone?

   Most Common : Inflammation of throat and nasal passages, back pain and upper respiratory tract infection.
   Miscellaneous : Nausea or vomiting, stomach pain, loss of appetite, fractures, low blood sugar, vision changes.

What are the other precautions for Alogliptin and Pioglitazone?

Avoid excess dosage.

What are the storage conditions for Alogliptin and Pioglitazone?

Store it at room temperature (20°C to 25°C).
Last Updated : Jul 2018



Advertisement
Recommended Reading

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.

Comments

osama99, Egypt

Dear, Sirs i am researcher in the pharmaceutical field from Egypt and i want to gain [Oseni] and its active constituents (Alogliptin and Pioglitazone) for some pharmaceutical researches.

Drugs A - Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs Search


    Advertisement
    What's New on Medindia
    Vaccination  And Counter  Measures Against  Monkeypox
    Indian Railways Special Concession on Health Grounds
    COVID Toes
    View all

    Medindia Newsletters Subscribe to our Free Newsletters!
    Terms & Conditions and Privacy Policy.

    Most Popular on Medindia

    How to Reduce School Bag Weight - Simple Tips Loram (2 mg) (Lorazepam) Noscaphene (Noscapine) Sanatogen Diaphragmatic Hernia Calculate Ideal Weight for Infants Hearing Loss Calculator Drug Interaction Checker Drug Side Effects Calculator Daily Calorie Requirements

    Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

    © All Rights Reserved 1997 - 2022

    This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use